Article Details
Retrieved on: 2025-02-07 20:21:41
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Modafinil, a wakefulness-promoting agent, and its FDA-approved uses, along with its off-label application for Alzheimer's and other disorders. It relates to the key concept by mentioning Alzheimer's disease among its off-label uses.
Article found on: www.republicworld.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here